MMP9 and coronary artery disorder: There were significantly higher levels of MMP-9 in the subgroup with self-reported CAD (n = 16) compared to participants without reported symptomatic CAD (mean: 52.7 (SD 34.5) vs 38.7 (SD 22.1) ng/mL, p = 0.017).